alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE>                5
<CIK>                    0000919957
<NAME>                   NTL (BERMUDA) LLC
<CURRENCY>               U.K. POUNDS

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               SEP-30-1999
<EXCHANGE-RATE>                                 1.6464
<CASH>                                          19,135
<SECURITIES>                                         0
<RECEIVABLES>                                    9,282
<ALLOWANCES>                                   (3,762)
<INVENTORY>                                          0
<CURRENT-ASSETS>                                29,699
<PP&E>                                         420,396
<DEPRECIATION>                                (79,766)
<TOTAL-ASSETS>                                 483,643
<CURRENT-LIABILITIES>                           24,755
<BONDS>                                        282,321
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             8
<OTHER-SE>                                     176,559
<TOTAL-LIABILITY-AND-EQUITY>                   483,643
<SALES>                                         72,240
<TOTAL-REVENUES>                                72,240
<CGS>                                                0
<TOTAL-COSTS>                                 (80,197)
<OTHER-EXPENSES>                               (9,173)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                            (23,650)
<INCOME-PRETAX>                               (37,215)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (37,215)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (37,215)
<EPS-BASIC>                                          0
<EPS-DILUTED>                                        0


</TABLE>
<PAGE>

                                                                    Exhibit 99.1

                            CERTIFICATION PURSUANT TO
            SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as
Chief Executive Officer of Point Therapeutics, Inc. (the "Company"), does hereby
certify that to the undersigned's knowledge:

     1)   The Company's Quarterly Report on Form 10-Q for the quarter ended June
          30, 2002 fully complies with the requirements of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     2)   The information contained in the Company's Quarterly Report on Form
          10-Q for the quarter ended June 30, 2002 fairly presents, in all
          material respects, the financial condition and results of operations
          of the Company.


                                    /s/ Donald R. Kiepert, Jr.
                                    --------------------------

                                    Donald R. Kiepert, Jr.
                                    Chief Executive Officer


Dated: August 8, 2002
<TABLE> <S> <C>

<ARTICLE>                     5
<CIK>                         0000919964
<NAME>                        BETTIS CORPORATION
<MULTIPLIER>                                   1,000
<CURRENCY>                                     U.S. DOLLARS
       
<S>                                        <C>
<PERIOD-TYPE>                                   9-MOS
<FISCAL-YEAR-END>                         DEC-31-1996
<PERIOD-START>                            JAN-01-1996
<PERIOD-END>                              SEP-30-1996
<EXCHANGE-RATE>                                 1.000
<CASH>                                          1,322
<SECURITIES>                                        0
<RECEIVABLES>                                  19,118
<ALLOWANCES>                                      412
<INVENTORY>                                    19,151
<CURRENT-ASSETS>                                1,880
<PP&E>                                         47,252
<DEPRECIATION>                                 24,688
<TOTAL-ASSETS>                                 78,197
<CURRENT-LIABILITIES>                          23,594
<BONDS>                                             0
<PREFERRED-MANDATORY>                               0
<PREFERRED>                                         0
<COMMON>                                           85
<OTHER-SE>                                     22,899
<TOTAL-LIABILITY-AND-EQUITY>                   78,197
<SALES>                                        52,114
<TOTAL-REVENUES>                               52,114
<CGS>                                          34,858
<TOTAL-COSTS>                                  46,891
<OTHER-EXPENSES>                                   (2)
<LOSS-PROVISION>                                    0
<INTEREST-EXPENSE>                              1,262
<INCOME-PRETAX>                                 3,963
<INCOME-TAX>                                    1,719
<INCOME-CONTINUING>                             2,244
<DISCONTINUED>                                      0
<EXTRAORDINARY>                                     0
<CHANGES>                                           0
<NET-INCOME>                                    2,244
<EPS-PRIMARY>                                     .26
<EPS-DILUTED>                                     .26
        

</TABLE>
##### 



Exhibit 32.2 Written Statement
Pursuant To
18 U.S.C. Section 1350 The undersigned, Brent W. Christensen, the Chief Financial Officer of Meade Instruments Corp.
(the Company), pursuant to 18 U.S.C. ss. 1350, hereby certifies that: (i) the Form 10-K for the fiscal year ended February 28, 2005 of the Company (the Report)
fully complies with the requirements of section 13(a) and 15(d) of the Securities Exchange Act of
1934; and (ii) the information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company. Date: May 31, 2005 By: /s/ Brent W. Christensen
Amendment No. 3 to 1997 Stock Option Plan


 Exhibit 4.8 
  

CHENIERE ENERGY, INC. 1997 STOCK OPTION PLAN 
 AMENDMENT No. 3 
  
 INCREASING NUMBER OF SHARES
SUBJECT TO PLAN 
  
 The Company’s Board of Directors and
stockholders have approved and declared the advisability of amending the Company’s 1997 Stock Option Plan to increase the total number of shares subject to the Plan from 1,500,000 to 2,000,000. 
  
 This Amendment No. 3 hereby changes the first sentence of Article V Section
5.1 to read: 
  
 “Subject to adjustment pursuant to the
provisions of Section 5.2 hereof, the maximum number of shares of Common Stock which may be issued and sold hereunder shall be 2,000,000.”
Fourth Court of Appeals

San Antonio, Texas

JUDGMENT

No. 04-15-00379-CV

IN THE INTEREST OF A.T.L., a Child

From the 37th Judicial District Court, Bexar County, Texas

Trial Court No. 2014-PA-00966

Honorable Antonia Arteaga, Judge Presiding

BEFORE CHIEF JUSTICE MARION, JUSTICE ANGELINI, AND JUSTICE BARNARD

In accordance with this court’s opinion of this date, the trial court’s Order of Termination 

is AFFIRMED.

No costs of appeal are assessed because appellant is indigent.

SIGNED October 28, 2015.

_____________________________

Sandee Bryan Marion, Chief Justice
I 

110TH CONGRESS 

1ST SESSION H. R. 1277 

To direct the Secretary of Health and Human Services to investigate how 

to eliminate the gap in benefits between standard coverage and catastrophic coverage under the Medicare prescription drug program under 

part D of title XVIII of the Social Security Act. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 1, 2007 

Mr. BUTTERFIELD (for himself, Mr. WYNN, Mr. WEINER, Mr. MEEKS of New 

York, Mr. JONES of North Carolina, Mr. BRADY of Pennsylvania, Mrs. 

CHRISTENSEN, Mr. AL GREEN of Texas, and Mr. MILLER of North Carolina) introduced the following bill; which was referred to the Committee 

on Energy and Commerce, and in addition to the Committee on Ways 

and Means, for a period to be subsequently determined by the Speaker, 

in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned 

A BILL 

To direct the Secretary of Health and Human Services to 

investigate how to eliminate the gap in benefits between 

standard coverage and catastrophic coverage under the 

Medicare prescription drug program under part D of 

title XVIII of the Social Security Act. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


hmoore on PROD1PC68 with HMBILLS
2 

•HR 1277 IH

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Medicare Prescription 

3 Drug Benefits Gap Elimination Act of 2007’’. 

4 SEC. 2. DIRECTING SECRETARY TO INVESTIGATE SOLU5 TIONS TO ELIMINATE BENEFIT GAP UNDER 

6 MEDICARE PRESCRIPTION DRUG COVERAGE. 

7 The Secretary of Health and Human Services (in this 

8 Act referred to as the ‘‘Secretary’’) shall conduct a study 

9 to investigate how to eliminate the gap in benefits for cov10 ered part D drugs under the Medicare prescription drug 

11 program under part D of title XVIII of the Social Security 

12 Act after a part D eligible individual’s costs exceed the 

13 initial coverage limit, as described in section 1860D– 

14 2(b)(3) of the Social Security Act (42 U.S.C. 1395w– 

15 102(b)(3)), and before the individual obtains protection 

16 against high out-of-pocket expenditures under section 

17 1860D–2(b)(4) of such Act (42 U.S.C. 1395w–102(b)(4)). 

18 SEC. 3. REPORT. 

19 Not later than 6 months after the date of enactment 

20 of this Act, the Secretary shall submit a report to Con21 gress on the findings from the study conducted under sec22 tion 2 and shall include in the report recommendations 

23 for legislation based on those findings. 

Æ 


hmoore on PROD1PC68 with HMBILLS
News United States Air Force
 USAFE, ANG squadrons strengthen teams in EstoniaPublished Sept. 6, 2016
                        
                        By Senior Airman Erin Trower
                        
                        
                        48th Fighter Wing Public Affairs
                **Ämari Air Base, Estonia (AFNS) --**
                U.S. Air Force and allied partners completed a multilateral flying training deployment in Estonia Sept. 2. The event served to enhance unit readiness and interoperability.
The 493rd Fighter Squadron  based out of Royal Air Force Lakenheath, England, and the California Air National Guard’s 194th Expeditionary Flying Squadron, flew alongside allied nations to enhance capabilities and demonstrate their commitment to European security and stability. 
“It was a tremendous opportunity for the (194th EFS) to train and integrate with the (493rd FS) Reapers,” said Lt. Col. Robert Swertfager, 194th EFS commander. “The amount of instructor time and the amount of support we got from the 493rd was top shelf.”
The two squadrons participated in the FTD with Estonian, Swedish, Finnish and U.K. aircraft and personnel to focus on dissimilar air training and test their capabilities against each other. 
According to Lt. Col. Jason Zumwalt, 493rd FS commander, bringing the five nations together to train effectively took time, but was well worth the effort.
“When you start out with a new team, with a bunch of members who have never worked together, there’s that awkward phase where you’re not very good working together and performance is low,” he said. “We are always trying to get to know each other and find out what each group’s strengths and weaknesses are, and, once that happens, the team performs very well together.”
The pilots practiced various tactics and offensive and defensive counter air operations to enhance their readiness, while building resilient relationships with each other and the participating forces. 
“What this FTD provides us is building trust with other countries around Europe,” Zumwalt said. “Getting together, finding out our roles and building relationships to build that trust.”
The FTD supported Operation Atlantic Resolve in an effort to demonstrate the U.S.’s commitment to NATO, allied partnerships, and European security. More than 300 Airmen participated in the FTD to help make the routine rotational deployment a successful operation.Estonia 



joint 



RAF Lakenheath 



England 



USAFE 



ANG
<PAGE>

                                                                    Exhibit 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

       In connection with the Quarterly Report of Renal Care Group, Inc. (the
"Company") on Form 10-Q for the period ended March 31, 2004 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Gary A.
Brukardt, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that, to my knowledge:

  (1)  The Report fully complies with the requirements of section 13(a) or 15(d)
       of the Securities Exchange Act of 1934; and

  (2)  The information contained in the Report fairly presents, in all material
       respects, the financial condition and results of operations of the
       Company.

/s/ Gary A. Brukardt
--------------------------------
Gary A. Brukardt
Chief Executive Officer
May 10, 2004
**EXHIBIT 32.1**

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEFFINANCIAL OFFICERPURSUANT TO18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

I,James S.J. Manuso, certify, pursuant to 18 U.S.C. Section 1350, as adoptedpursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that theQuarterly Report of SuperGen, Inc. on Form 10-Q for thequarterly period ended June 30, 2005 fully complies with the requirementsof Section 13(a) or 15(d) of the Securities Exchange Act of 1934and that information contained in such Form 10-Q fairly presents inall material respects the financial condition and results of operations ofSuperGen, Inc.
|        | By:    | /s/ JAMES  S.J. MANUSO                   |
|--------|--------|------------------------------------------|
|   | Name:  | James S.J. Manuso                        |
|   | Title: | *President and  Chief Executive Officer* |
|   |   | *(Principal  Executive Officer)*         |

 

I,Michael Molkentin, certify, pursuant to 18 U.S.C. Section 1350, as adoptedpursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that theQuarterly Report of SuperGen, Inc. on Form 10-Q for thequarterly period ended June 30, 2005 fully complies with the requirementsof Section 13(a) or 15(d) of the Securities Exchange Act of 1934and that information contained in such Form 10-Q fairly presents inall material respects the financial condition and results of operations ofSuperGen, Inc.
|        | By:    | /s/ MICHAEL  MOLKENTIN                         |
|--------|--------|------------------------------------------------|
|   | Name:  | Michael Molkentin                              |
|   | Title: | *Chief Financial Officer*                      |
|   |   | *(Principal Financial and Accounting Officer)* |

 

----
#### STATE OF NEW JERSEY v. G.B.

March 27, 1984.

Petition for certification denied.
583 A.2d 338

#### SULIMAN SHABAZZ v. NEW JERSEY STATE PAROLE BOARD.

March 7, 1990.

Petition for certification denied.
IIB 

110TH CONGRESS 

1ST SESSION H. R. 1260 

IN THE SENATE OF THE UNITED STATES 

MAY 15, 2007 

Received; read twice and referred to the Committee on Homeland Security and 

Governmental Affairs 

AN ACT 

To designate the facility of the United States Postal Service 

located at 6301 Highway 58 in Harrison, Tennessee, 

as the ‘‘Claude Ramsey Post Office’’. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

mstockstill on PROD1PC66 with BILLS

2 

HR 1260 RFS

1 SECTION 1. CLAUDE RAMSEY POST OFFICE. 

2 (a) DESIGNATION.—The facility of the United States 

3 Postal Service located at 6301 Highway 58 in Harrison, 

4 Tennessee, shall be known and designated as the ‘‘Claude 

5 Ramsey Post Office’’. 

6 (b) REFERENCES.—Any reference in a law, map, reg7 ulation, document, paper, or other record of the United 

8 States to the facility referred to in subsection (a) shall 

9 be deemed to be a reference to the ‘‘Claude Ramsey Post 

10 Office’’. 

Passed the House of Representatives May 14, 2007. 

Attest: LORRAINE C. MILLER, 

Clerk. 

mstockstill on PROD1PC66 with BILLS
News United States Air Force
 TRICARE to expand preventive service coveragePublished Oct. 21, 2016
                        
                        By TRICARE Staff
                        
                        
                        TRICARE
                **FALLS CHURCH, Va. (AFNS) --**
                TRICARE has always had excellent coverage of important preventive services and they are making it better. TRICARE is adding preventive services to ensure alignment with recommendations of the U.S. Preventive Services Task Force, and the U.S. Health Resources and Services Administration’s guidelines.   
Effective Jan.1, 2017, TRICARE will cover annual preventive office visits for all Prime beneficiaries 6 years of age and older. Children under 6 are already covered by existing well-child coverage. This will ensure children in developing stages receive observation, physical examination, screening, immunizations, and various counseling services. TRICARE Standard beneficiaries can receive preventive services with no cost-share or copayment through Health Promotion and Disease Prevention examinations (i.e., in connection with a covered immunization or cancer screening).
Additionally, the annual well-woman exam will continue to be covered for all Prime and Standard beneficiaries under age 65 with no cost-share or copayment. The new covered services include free genetic counseling by a TRICARE-authorized provider before BRCA1 or BRCA2 gene testing for women who are identified as high risk for breast cancer by their primary care providers, as well as the BRCA1 or BRCA2 gene testing for women who meet coverage guidelines under the existing laboratory developed test demonstration project.
TRICARE will also cover stool DNA testing (e.g., Cologuard) once every 3 years starting at age 50 for those who have an average risk of colon cancer.  The effective date of Cologuard coverage is June 21, 2016. 
If anyone has recently received any of these services, they are advised to save their receipts and file a claim.  The regional contractors will be ready to process claims for the new preventive benefits on Nov. 14, 2016, the implementation date of this change.  The implementation date is the date the contractor must be ready to communicate and process claims for this benefit. 
For more information on medical claimsand covered services, visit the TRICARE website.AFMS 



preventive health 



TRICARE
#### C. W. Kleaden v. C. T. Reynolds *&*Co.

(No. 983, Op. Book No. 2, p. 310.)

Error from Washington County.

January 26, 1881.

Opinion by

Hurt, J.

§ 773. *Return of service of citation held sufficient.*There was judgment by default. The return of the sheriff' upon the citation was as follows: “ Came to hand on the 4th day of August, 1877, and executed on the same day by delivering to the within named, O. W. Kleaden, a true copy of this writ.” It was objected to this return that it did not show that service was made upon “the defendant in person.” *Held,*the process commanded service to be made upon O. W. Kleaden; the sheriff, in his return, says-that he delivered a true copy of the writ to the C. W. Kleaden named therein. The objection to the return is. not well taken.

Affirmed.
#### H. B. Caston et al. v. Mary Dawson et al.

(No. 2711.)

November 23, 1887.

Appeal from Rusk County.

J. H. Turner, counsel for appellant.

H. O. Stone, counsel for appellee.

Opinion by

Willson, J.

§ 332. *Lost note; execution of, may be proved, how; case stated.*Suit by appellees against appellants upon a promissory note secured by a chattel mortgage. Judgment for* appellees. On the trial it was shown that the note sued upon was lost. The mortgage given to secure the note was read in evidence and recited a note of the same date, for the same amount, due at the same date, and payable to the same party as the note set out in the petition. *Held*that, *prima facie,*said recital proved the execution of the note set out in the petition; it being shown that the note sued upon had been correctly copied into the petition. When a lost note is the basis of an action it devolves upon the plaintiff not only to prove the loss of the note, but to prove also its execution by the defendant. [R. S. art. 1265, subd. 8; Erskine v. Wilson, 20 Tex. 78; Robinson v. Brinson, id. 438.] Several other questions are discussed and decided in this opinion, but they are not of sufficient importance to be reported.

Affirmed.
#### STATE ex rel. Carlos Delugo JOHNSON v. STATE of Louisiana.

No. 2011-KH-0156.

Supreme Court of Louisiana.

Dec. 2, 2011.

In re Johnson, Carlos Delugo; — Plaintiff; Applying For Supervisory and/or Remedial Writs, Parish of Bossier, 26th Judicial District Court Div. C, No. 84,975; to the Court of Appeal, Second Circuit, No. 46,198-KH.

Denied. La.C.Cr.P. art. 930.8; *State ex rel. Glover v. State,*93-2330 (La.9/5/95), 660 So.2d 1189; La.C.Cr.P. art. 930.3; *State ex rel. Melinie v. State,*93-1380 (La.1/12/96), 665 So.2d 1172.